Apollo Hospitals to list its pharmacy and digital health business in 18-21 months

Apollo Hospitals Enterprise Limited (AHEL) announced that it plans to list multi-channel pharmacy and digital health business as part of a strategic restructuring in the next 18-21 months on Monday.

The Board of Directors of the company approved the multi -channel pharmaceutical and digital health business through an Apollo Healthco’s composite arrangement scheme to a new organization (Newco). After Dememerger, Apollo’s wholesale drug distributor Keimed last year will be combined with Newco.

Apollo Hospitals shares will have direct shareholders in the combined organization. The company said that for every 100 shares of Ahel, the shareholders will receive 195.2 shares of the new organization.

Integrated ecosystem

The proposed procedure will result in the creation of the largest, integrated multi -channel health ecosystem with 25 financial income. LaThe company is 16,300 Crore ($ 1.9 billion) in 25 financial years.

7/24 Apollo, Digital Health Platform, Offline Pharma Distribution business, Keimed and Telehealth Services, including the new job, is expected to generate revenue. La27 In the financial year 25,000 Crore ($ 2.9 billion).

In an interview Mint Last week, Shobana Kamineni, the manager of Apollo Healthco LaIt is an exponential valuation of 30,000 Crore in the next five to six years because it grows up.

The list is expected within 18 to 21 months. Newco will be an Indian and controlled company (IOCC) after the plan has entered into force. Newco, Apollo Medicals Pvt. LTD (Ampl) with 100% of Apollo Healthco. The company said Newco will enable retail pharmacies to participate in the business economy.

Ahel will have 15% shares in Newco and will be a candidate manager on the Newco board of directors.